Resumo

CUEVAS, Iván E. Presente y futuro de la farmacovigilancia en la Industria Farmacéutica. Vaccimonitor [online]. 2007, vol.16, n.1, pp. 20-25. ISSN 1025-0298.

A study about problems of post-commercialization surveillance in the pharmaceutical industry was carried out. Adverse reactions to medicines and vaccines cause a significant increase in the costs of sanitary assistance; vaccines in particular have a deferred and unknown benefit and an immediate risk. This is the reason why higher surveillance standards are required. Pharmaco-surveillance by itself presents obstacles which can be greater when they are focused on from the pharmaceutical industry. Company or sponsorship as strategy allows overcoming these obstacles and establishing the post-commercialization surveillance system which has been systematic practice of Finlay Institute. The experience of our Institute where all factors and conditions influencing on products are observed is an advance to obtain a better evaluation of the sanitary and economic impact on the application of our vaccines. Implementation and starting of pharmaco-surveillance in the medicine industry is a challenge and a necessity to complete the development of the pharmaceutical industry.

Palavras-chave : Vaccines; pharmaco-surveillance; adverse reactions.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )